// App-Quantinova.ai

5051 : Combinatorial genomic and pathological indices for integrated stratification of unfavorable intermediate-risk prostate cancer.

Researchers

Presenter

  • Melvin Chua

Principal Investigators

  • Jure Murgic

  • Melania Pintilie

  • Emilie Lalonde

  • Alejandro Berlin

  • Julie Livingstone

  • Alan Dal Pra

  • Alice Meng

  • Junyan Zhang

  • Yves Fradet

  • Bernard Tetu

  • Neil Eric Fleshner

  • Michael Fraser

  • Paul Boutros

  • Theodorus van der Kwast

  • Robert G. Bristow

Medical Centers

  • Radiation Medicine Program, Princess Margaret Hospital, Toronto, Canada, Toronto, ON, Canada

  • Department of Oncology University Hospital Center Sisters of Mercy University of Zagreb Medical School, Zagreb, Croatia

  • Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Ontario Institute for Cancer Research, Toronto, ON, Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Informatics & Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON, Canada

  • Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland

  • STTARR Innovation Centre, Radiation Medicine Program, Princess Margaret Cancer Centre/University Health Network, University of Toronto, Toronto, ON, Canada

  • Radiation Medicine Program Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Department of Urology, Laval University, Quebec, QC, Canada

  • Department of Pathology and Research Center, CHUQ, L'Hotel-Dieu de Quebec, Quebec, QC, Canada

  • Department of Pathology, University Health Network, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

  • Switzerland

  • Croatia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved